Search by Drug Name or NDC

    NDC 70934-0360-30 ATORVASTATIN CALCIUM 20 mg/1 Details

    ATORVASTATIN CALCIUM 20 mg/1

    ATORVASTATIN CALCIUM is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Denton Pharma, Inc. DBA Northwind Pharmaceuticals. The primary component is ATORVASTATIN CALCIUM TRIHYDRATE.

    Product Information

    NDC 70934-0360
    Product ID 70934-360_d218af0e-6f34-76d6-e053-2a95a90a032c
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name ATORVASTATIN CALCIUM
    Proprietary Name Suffix n/a
    Non-Proprietary Name ATORVASTATIN CALCIUM
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 20
    Active Ingredient Units mg/1
    Substance Name ATORVASTATIN CALCIUM TRIHYDRATE
    Labeler Name Denton Pharma, Inc. DBA Northwind Pharmaceuticals
    Pharmaceutical Class HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA207687
    Listing Certified Through 2022-12-31

    Package

    NDC 70934-0360-30 (70934036030)

    NDC Package Code 70934-360-30
    Billing NDC 70934036030
    Package 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70934-360-30)
    Marketing Start Date 2019-05-06
    NDC Exclude Flag N
    Pricing Information N/A